Overview

Glycomics / Glycobiology Market is estimated to value over USD 2.5 billion by 2027 end with a CAGR of over 13.5% during the forecast period 2020 to 2027.

The rising research and development activities pertaining to glycomics, increased investments by biotech and pharma companies and rising demand for proteomics are some of the key factors driving the glycomics/glycobiology market growth. Furthermore, the glycoscience sector is growing rapidly and glycans are crucial in biological research and processes in understanding biology in a comprehensive manner. As per the Biotech Briefing in 2018, the average expenditure for research and development of biotechnology companies has risen by over 15% from 2016 to 2017. Furthermore, the government bodies are increasingly involved in undertaking the initiatives for conducting extensive research activities related to glycomics. For instance, the Australian government has invested over USD 10 billion for research innovations and activities during the period 2017-2018. Furthermore, the Irish government declared an expenditure of over USD 5 billion in 2015 for increasing research activities across the country. Such initiatives shall boost the growth of the market.

Glycomics / Glycobiology Market

Market Segmentation:

By Product
•   Enzymes
o Glycosidases
o Neuraminidases
o Glycosyltransferases
o Sialyltransferases
o Others
•   Kits
o Glycan Labeling Kits
o Glycan Purification Kits
o Glycan Release Kits
o Others
•   Reagents
o Glycoproteins
o Monosaccharides
o Oligosaccharides
o Others
•   Instruments
o Mass Spectrometers
o HPLC
o MALDI-TOF
o Array Systems
o Others
By Application
•   Drug Discovery & Development
•   Disease Diagnostics
•   Other Applications
By End User
•   Academic Research Institutes
•   Pharmaceutical and Biotechnology Companies
•   Clinical Laboratories
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is bifurcated into product, application, end user and region. The product segment is categorized into enzymes, instruments, kits, carbohydrates and reagents & chemicals. The enzymes segment is predicted to hold the largest glycomics/glycobiology market share owing to the wide range of applications in diagnostics and research and increased sale of these products. The application segment is categorized into drug discovery and development, disease diagnostics and other applications. The drug discovery and development segment is predicted to lead the market and this can be credited to an increased insistence for personalized medicines and emphasis on advanced drug development. The end user segment is fragmented into academic research institutes, pharmaceutical and biotechnology companies and clinical laboratories. The pharmaceutical and biotechnology company segment is anticipated to dominate the market owing to the rise in the number of investments made by these companies for research and development of glycomics.

Regional Analysis:

The North America region is expected to subjugate the market, and this can be primarily credited to increased investments in research activities pertaining to glycomics and a strong presence of key market players in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecasted timeframe owing to the increased healthcare expenditure and operational expanse of biotech and pharma companies in the region.

Competitive Landscape:

The key market players included are Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation, Asparia Glycomics S.L., Bio-Techne, Bruker Corporation, Danaher Corporation, RayBiotech, Z Biotech, Chemily Glycoscience, Dextra Laboratories, Lectenz Bio, Ludger Ltd.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global glycomics/glycobiology market by product, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com